What to look out for in penny land:
Key developments
Xechem International Inc. Appoints Robert Swift as Chief Oversight Officer
08/20/2007
Xechem International Inc. announced that Dr. Robert Swift, the interim chief operating officer has assumed the position of Chief Oversight Officer, in lieu of the former position, vested with the authority to act on behalf of the Company, pending appointment of a full time chief executive officer.
Xechem International Inc. will Change its Ticker to XKEME from XKEM
08/16/2007
Effective August 20, 2007, Xechem International Inc. will change its OTCBB stock ticker symbol to XKEME from XKEM.
Xechem International Inc. Appoints Robert Swift as Chairman of the Board of Directors, Interim CEO and Interim President of the Company
07/11/2007
Effective July 5, 2007 the Board of Directors of Xechem International Inc. appointed Dr. Robert Swift to serve as Chairman of the Board of Directors of the Company, interim CEO and interim President of the Company. Effective as of such appointment, Dr. Ramesh Pandey, the former Chairman of the Board of Directors, CEO and President of the Company no longer serves as an officer of the Company or Chairman of the Board of Directors, but continues to serve on its Board of Directors.
Colonel Bhuwan Pandey Leaves Xechem International Inc. as Vice President, International Operations
06/15/2007
Xechem International Inc. announced that Colonel Bhuwan Pandey, Vice President, International Operations, was relieved of his duties with the Company, effective June 12, 2007. Colonel Pandey has an employment agreement with the Company that calls for payment of six months compensation in such event absent termination for cause.
Xechem International Inc. Announces Executive Appointments
05/30/2007
Xechem International Inc. announced that it has hired H. Scott English as the company internal Director of Investor Relations and Benjamin S. White III as the Director of Finance and Accounting. Scott is the Founder of The Halsey Group, LLC an international business development firm which specializes in Biopharmaceutical/High Tech Sales and Public Relations. Ben White was with Xechem in the early years as both a financial consultant and Controller and was the key financial manager during Xechem's IPO in 1994. Ben is a financial executive with over 30 years experience and has an established track record of revenue enhancements, cost reductions, cash management, fraud detections, and operations coordination/consolidation.
BUT STILL HOLDING STRONG AND BELIEVING IN NICOSAN/HEMOXIN
AI
